Analystreport

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was upgraded by analysts at LADENBURG THALM/SH SH from a "neutral" rating to a "buy" rating.

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com